Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,792,230
-
Share change
-
+4,192,197
-
Total reported value
-
$194,660,626
-
Put/Call ratio
-
217%
-
Price per share
-
$5.44
-
Number of holders
-
143
-
Value change
-
+$23,757,191
-
Number of buys
-
87
-
Number of sells
-
40
Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q3 2024
As of 30 Sep 2024,
Humacyte, Inc. - COM (HUMA) was held by
143 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,792,230 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, VOLORIDGE INVESTMENT MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, Woodline Partners LP, GOLDMAN SACHS GROUP INC, and NORTHERN TRUST CORP.
This page lists
143
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.